APA (7th ed.) Citation

TY, W., KY, L., LH, S., HY, S., YS, H., WD, L., . . . CC, H. (2024). Sexually transmitted coinfections among at-risk HIV-positive MSM: Implications for optimal preemptive treatment. Frontiers in medicine, 11, 1328589. https://doi.org/10.3389/fmed.2024.1328589

Chicago Style (17th ed.) Citation

TY, Wu, et al. "Sexually Transmitted Coinfections Among At-risk HIV-positive MSM: Implications for Optimal Preemptive Treatment." Frontiers in Medicine 11 (2024): 1328589. https://doi.org/10.3389/fmed.2024.1328589.

MLA (9th ed.) Citation

TY, Wu, et al. "Sexually Transmitted Coinfections Among At-risk HIV-positive MSM: Implications for Optimal Preemptive Treatment." Frontiers in Medicine, vol. 11, 2024, p. 1328589, https://doi.org/10.3389/fmed.2024.1328589.